Agenda - Sixteenth industry stakeholder platform on research and development support
Submitted by Anonymous (not verified) on 9 July 2026 - 14:41
Agenda - Sixteenth industry stakeholder platform on research and development support
Human medicines European public assessment report (EPAR): Evkeeza, evinacumab, Date of authorisation: 17/06/2021, Revision: 12, Status: Authorised
Submitted by Anonymous (not verified) on 9 July 2026 - 14:30
Human medicines European public assessment report (EPAR): Evkeeza, evinacumab, Date of authorisation: 17/06/2021, Revision: 12, Status: Authorised
Human medicines European public assessment report (EPAR): Pyrukynd, mitapivat, Date of authorisation: 09/11/2022, Revision: 3, Status: Authorised
Submitted by Anonymous (not verified) on 9 July 2026 - 12:52
Human medicines European public assessment report (EPAR): Pyrukynd, mitapivat, Date of authorisation: 09/11/2022, Revision: 3, Status: Authorised
Dates of 2027 SAWP meetings and submission deadlines Scientific advice, protocol assistance, qualification of biomarkers and parallel HTACG/EMA Joint Scientific Consultation requests
Submitted by Anonymous (not verified) on 9 July 2026 - 12:49
Dates of 2027 SAWP meetings and submission deadlines Scientific advice, protocol assistance, qualification of biomarkers and parallel HTACG/EMA Joint Scientific Consultation requests
Sixteenth meeting of the industry stakeholder platform on the operation of the centralised procedure for human medicines, Online, European Medicines Agency, Amsterdam, the Netherlands, from 15 June 2026, 13:00 (CEST) to 15 June 2026, 18:00 (CEST)
Submitted by Anonymous (not verified) on 9 July 2026 - 12:44
Sixteenth meeting of the industry stakeholder platform on the operation of the centralised procedure for human medicines, Online, European Medicines Agency, Amsterdam, the Netherlands, from 15 June 2026, 13:00 (CEST) to 15 June 2026, 18:00 (CEST)
Human medicines European public assessment report (EPAR): Locametz, gozetotide, Date of authorisation: 09/12/2022, Revision: 8, Status: Authorised
Submitted by Anonymous (not verified) on 9 July 2026 - 11:30
Human medicines European public assessment report (EPAR): Locametz, gozetotide, Date of authorisation: 09/12/2022, Revision: 8, Status: Authorised
Sixteenth industry stakeholder platform on research and development support, European Medicines Agency, Amsterdam, the Netherlands, from 2 July 2026, 12:30 (CEST) to 2 July 2026, 17:30 (CEST)
Submitted by Anonymous (not verified) on 9 July 2026 - 11:03
Sixteenth industry stakeholder platform on research and development support, European Medicines Agency, Amsterdam, the Netherlands, from 2 July 2026, 12:30 (CEST) to 2 July 2026, 17:30 (CEST)
Presentation - SPOR and XEVMPD status update webinar - Q3 2026
Submitted by Anonymous (not verified) on 9 July 2026 - 9:10
Presentation - SPOR and XEVMPD status update webinar - Q3 2026
International arrangements
Submitted by Anonymous (not verified) on 8 July 2026 - 22:05
International arrangements
New Zealand
Submitted by Anonymous (not verified) on 8 July 2026 - 21:59
New Zealand